S&P 500   3,959.31 (-0.11%)
DOW   33,702.72 (-0.23%)
QQQ   283.23 (-0.22%)
AAPL   142.06 (-0.41%)
MSFT   244.98 (-0.98%)
META   115.56 (+0.20%)
GOOGL   93.73 (+0.02%)
AMZN   89.40 (-1.05%)
TSLA   178.02 (+2.64%)
NVDA   172.96 (+0.74%)
NIO   13.06 (-2.61%)
BABA   92.97 (-1.27%)
AMD   69.35 (-1.59%)
T   19.24 (+0.63%)
MU   55.32 (+0.22%)
CGC   2.99 (-3.24%)
F   13.27 (+1.14%)
GE   82.31 (-1.58%)
DIS   93.59 (+1.12%)
AMC   6.02 (-0.82%)
PYPL   74.16 (-0.08%)
PFE   51.82 (+0.08%)
NFLX   324.02 (+4.43%)
S&P 500   3,959.31 (-0.11%)
DOW   33,702.72 (-0.23%)
QQQ   283.23 (-0.22%)
AAPL   142.06 (-0.41%)
MSFT   244.98 (-0.98%)
META   115.56 (+0.20%)
GOOGL   93.73 (+0.02%)
AMZN   89.40 (-1.05%)
TSLA   178.02 (+2.64%)
NVDA   172.96 (+0.74%)
NIO   13.06 (-2.61%)
BABA   92.97 (-1.27%)
AMD   69.35 (-1.59%)
T   19.24 (+0.63%)
MU   55.32 (+0.22%)
CGC   2.99 (-3.24%)
F   13.27 (+1.14%)
GE   82.31 (-1.58%)
DIS   93.59 (+1.12%)
AMC   6.02 (-0.82%)
PYPL   74.16 (-0.08%)
PFE   51.82 (+0.08%)
NFLX   324.02 (+4.43%)
S&P 500   3,959.31 (-0.11%)
DOW   33,702.72 (-0.23%)
QQQ   283.23 (-0.22%)
AAPL   142.06 (-0.41%)
MSFT   244.98 (-0.98%)
META   115.56 (+0.20%)
GOOGL   93.73 (+0.02%)
AMZN   89.40 (-1.05%)
TSLA   178.02 (+2.64%)
NVDA   172.96 (+0.74%)
NIO   13.06 (-2.61%)
BABA   92.97 (-1.27%)
AMD   69.35 (-1.59%)
T   19.24 (+0.63%)
MU   55.32 (+0.22%)
CGC   2.99 (-3.24%)
F   13.27 (+1.14%)
GE   82.31 (-1.58%)
DIS   93.59 (+1.12%)
AMC   6.02 (-0.82%)
PYPL   74.16 (-0.08%)
PFE   51.82 (+0.08%)
NFLX   324.02 (+4.43%)
S&P 500   3,959.31 (-0.11%)
DOW   33,702.72 (-0.23%)
QQQ   283.23 (-0.22%)
AAPL   142.06 (-0.41%)
MSFT   244.98 (-0.98%)
META   115.56 (+0.20%)
GOOGL   93.73 (+0.02%)
AMZN   89.40 (-1.05%)
TSLA   178.02 (+2.64%)
NVDA   172.96 (+0.74%)
NIO   13.06 (-2.61%)
BABA   92.97 (-1.27%)
AMD   69.35 (-1.59%)
T   19.24 (+0.63%)
MU   55.32 (+0.22%)
CGC   2.99 (-3.24%)
F   13.27 (+1.14%)
GE   82.31 (-1.58%)
DIS   93.59 (+1.12%)
AMC   6.02 (-0.82%)
PYPL   74.16 (-0.08%)
PFE   51.82 (+0.08%)
NFLX   324.02 (+4.43%)
LON:NIPT

Premaitha Health - NIPT Share Forecast, Price & News

GBX 9.10
+0.20 (+2.25%)
(As of 11/6/2018)
Add
Compare
Today's Range
9.10
9.10
50-Day Range
9.10
9.10
52-Week Range
3.78
14.80
Volume
1.57 million shs
Average Volume
1.35 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NIPT stock logo

About Premaitha Health (LON:NIPT) Stock

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

NIPT Stock News Headlines

Persimmon (LSE:PSN)
Premaitha Health Share Chat
(LSE:NIPT)
Recent Broker Ratings for Panmure Gordon
Who Owns Premaitha Health PLC (LON:NIPT)?
See More Headlines
Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

NIPT Company Calendar

Last Earnings
12/29/2017
Today
12/09/2022

Industry, Sector and Symbol

Industry
Medical Laboratories & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Stephen Little (Age 61)
    Exec. Vice Chairman
  • Mr. Barry Hextall
    CFO, Sec. & Exec. Director
  • Mr. Peter Collins (Age 59)
    Chief Bus. Officer & Exec. Director
  • Mr. Lyn Fafydd Rees (Age 45)
    CEO & Director
  • Dr. Chia-Han Chan (Age 42)
    Chief Scientific Officer & Director













NIPT Stock - Frequently Asked Questions

How have NIPT shares performed in 2022?

Premaitha Health's stock was trading at GBX 9.10 at the start of the year. Since then, NIPT shares have increased by 0.0% and is now trading at GBX 9.10.
View the best growth stocks for 2022 here
.

How were Premaitha Health's earnings last quarter?

Premaitha Health PLC (LON:NIPT) issued its earnings results on Friday, December, 29th. The company reported ($2.00) earnings per share for the quarter. The company earned $2.71 million during the quarter.

What other stocks do shareholders of Premaitha Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV).

What is Premaitha Health's stock symbol?

Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."

How do I buy shares of Premaitha Health?

Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Premaitha Health's stock price today?

One share of NIPT stock can currently be purchased for approximately GBX 9.10.

How can I contact Premaitha Health?

Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The official website for the company is www.premaitha.com. The company can be reached via phone at +44-161-6676865.

This page (LON:NIPT) was last updated on 12/9/2022 by MarketBeat.com Staff